Why has the epidemiology of RSV changed during the COVID-19 pandemic?

Bahaa Abu-Raya; Marina Viñeta Paramo; Frederic Reicherz; Pascal Michel Lavoie

doi:10.1016/j.eclinm.2023.102089

Why has the epidemiology of RSV changed during the COVID-19 pandemic?

EClinicalMedicine. 2023 Jul 6:61:102089. doi: 10.1016/j.eclinm.2023.102089. eCollection 2023 Jul.

Authors

Bahaa Abu-Raya^{1

2}, Marina Viñeta Paramo^{1

2}, Frederic Reicherz^{1

2}, Pascal Michel Lavoie^{1

2}

Affiliations

¹ Department of Pediatrics, University of British Columbia, Vancouver, Canada.
² British Columbia Children's Hospital Research Institute, Vancouver, Canada.

Abstract

The coronavirus disease 2019 (COVID-19) pandemic has drastically perturbed the epidemiology of Respiratory Syncytial Virus (RSV) respiratory tract infections in children. The reasons for this are not clear. In this article, we review the current literature and critically discuss the different theories to explain why the epidemiology of RSV has changed during the COVID-19 pandemic. Proposed mechanisms include decreased viral immunity in vulnerable age groups caused by the prolonged lack of RSV circulation early in the pandemic, potential Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2)-induced immune dysregulation, viral interactions between SARS-CoV-2 and RSV, and modifications in health-seeking behaviors as well as heath systems factors. Research in viral genomics and phylogeny, and more robust immunology research is needed to guide RSV prevention and health care resource planning.

Keywords: COVID-19; Co-infection; RSV; Resurgence; Waning immunity.

Publication types

Review